Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach

被引：0

作者：

Lassen, U. N. ^{[1
]}

Albert, C. M. ^{[2
]}

Kummar, S. ^{[3
]}

van Tilburg, C. M. ^{[4
,5
]}

Dubois, S. G. ^{[6
]}

Geoerger, B. ^{[7
]}

Mascarenhas, L. ^{[8
]}

Federman, N. ^{[9
]}

Schilder, R. J. ^{[10
]}

Doz, F. ^{[11
,12
]}

Berlin, J. D. ^{[13
]}

Oh, D-Y. ^{[14
]}

Bielack, S. S. ^{[15
]}

McDermott, R. ^{[16
]}

Tan, D. S. ^{[17
]}

Cruickshank, S. ^{[18
]}

Ku, N. C. ^{[18
]}

Cox, M. C. ^{[18
]}

Drilon, A. ^{[19
]}

Hong, D. S. ^{[20
]}

机构：

[1] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Finsen Ctr,Phase Unit 1, Copenhagen, Denmark

[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Childrens Hosp, Pediat Oncol, Seattle, WA 98195 USA

[3] Stanford Univ, Stanford Canc Inst, Med Oncol, Stanford, CA 94305 USA

[4] Univ Heidelberg Hosp, Hopp Childrens Canc Ctr, NCT Heidelberg KiTZ, Pediat Oncol, Heidelberg, Germany

[5] German Canc Res Ctr, Heidelberg, Germany

[6] Dana Farber Boston Childrens Canc & Blood Disorde, Pediat Oncol, Boston, MA USA

[7] Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France

[8] Univ Southern Calif, Keck Sch Med, Childrens Hosp Los Angeles, Oncol, Los Angeles, CA 90033 USA

[9] Univ Calif Los Angeles, Pediat Oncol, Los Angeles, CA USA

[10] Thomas Jefferson Univ, Med Oncol, Philadelphia, PA 19107 USA

[11] Inst Curie, Pediat Oncol, Paris, France

[12] Univ Paris 05, Paris, France

[13] Vanderbilt Ingram Canc Ctr, Med, Nashville, TN USA

[14] Seoul Natl Univ Hosp, Med Oncol, Seoul, South Korea

[15] Klinikum Stuttgart, Pediat Oncol, Olgahosp, Stuttgart, Germany

[16] AMNCH Adelaide & Meath Hosp, Med Oncol, Dublin, Ireland

[17] Natl Canc Ctr, Med Oncol, Singapore, Singapore

[18] Loxo Oncol, Clin Dev, San Francisco, CA USA

[19] Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA

[20] Univ Texas MD Anderson Canc Ctr, Med Oncol, Houston, TX 77030 USA

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

409O

引用

页码：133 / 133

页数：1

共 50 条

[31] Long-term efficacy and safety of larotrectinib in patients with TRK fusion lung cancer.
Drilon, Alexander E.
Kummar, Shivaani
Lin, Jessica Jiyeong
Tan, Daniel Shao-Weng
Moreno, Victor
Leyvraz, Serge
Dubashi, Biswajit
Haresh, K. P.
Burcoveanu, Domnita-Ileana
Neu, Natascha
Mussi, Chiara E.
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[32] Extended Follow-up of Efficacy and Safety of Larotrectinib in Patients With TRK Fusion Lung Cancer
Moreno, V.
Lin, J. J.
Tan, D. S. W.
Kummar, S.
Dai, M. -S.
Lassen, U. N.
Leyvraz, S.
Liu, Y.
Patel, J. D.
Rosen, L.
Solomon, B.
Yachnin, J.
Norenberg, R.
Fellous, M.
Mussi, C. E.
Shen, L.
Drilon, A.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S473 - S474
[33] Intra-patient (Pt) comparison from larotrectinib (Laro) clinical trials in tropomyosin receptor kinase (TRK) fusion cancer: An expanded dataset
Italiano, A.
Drilon, A. E.
Shen, L.
Hong, D. S.
van Tilburg, C.
Tan, D. S. W.
Lin, J. J.
Kummar, S.
Doz, F.
Geoerger, B.
Brose, M. S.
Briggs, A.
Lassen, U. N.
Vassal, G.
Keating, K. N.
Norenberg, R.
Dima, L.
Brega, N.
Laetsch, T.
Garcia-Foncillas, J.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S752 - S753
[34] Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer
Drilon, A.
Shen, L.
van Tilburg, C.
Doz, F.
Tan, D. S. W.
Lin, J. J.
Kummar, S.
Lassen, U. N.
McDermott, R. S.
Dierselhuis, M. P.
Albert, C. M.
Nagasubramanian, R.
Watt, T.
Patil, T.
Burcoveanu, D-I.
Norenberg, R.
Brega, N.
Laetsch, T. W.
Xu, R-H.
Hong, D. S.
ANNALS OF ONCOLOGY, 2023, 34 : S470 - S470
[35] Updated efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer.
Drilon, Alexander E.
Lin, Jessica Jiyeong
Kummar, Shivaani
Tan, Daniel Shao-Weng
Patel, Jyoti D.
Lassen, Ulrik Niels
Leyvraz, Serge
Moreno, Victor
Rosen, Lee S.
Solomon, Benjamin Maurice
Yachnin, Jeffrey
Liu, Yongmei
Dai, Ming-Shen
Norenberg, Ricarda
Fellous, Marc Mardoche
Mussi, Chiara Erminia
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[36] Updated efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion gastrointestinal (GI) cancer.
Shen, Lin
Andre, Thierry
Chung, Hyun Cheol Cheol
Deeken, John F.
Garralda, Elena
Italiano, Antoine
Leyvraz, Serge
Liu, Tianshu
Burcoveanu, Domnita-Ileana
Grugel, Robin
Mussi, Chiara E.
Xu, Rui-Hua
Hong, David S.
Drilon, Alexander E.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 109 - 109
[37] Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase (TRK) Fusion-Positive Lung Cancer
Drilon, A.
Lin, J.
Lassen, U.
Leyvraz, S.
Liu, Y.
Patel, J.
Rosen, L.
Solomon, B.
Norenberg, R.
Dima, L.
Brega, N.
Shen, L.
Moreno, V.
Kummar, S.
Tan, D.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1125 - S1126
[38] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Lin, Jessica Jiyeong
Tan, Daniel Shao-Weng
Kummar, Shivaani
Patel, Jyoti D.
Cermignani, Luciano
Dai, Ming-Shen
Lassen, Ulrik Niels
Leyvraz, Serge
Liu, Yongmei
Moreno, Victor
Rosen, Lee S.
Saada-Bouzid, Esma
Solomon, Benjamin Maurice
Xu, Rui-Hua
Yachnin, Jeffrey
Norenberg, Ricarda
Burcoveanu, Domnita-Ileana
Mussi, Chiara E.
Shen, Lin
Drilon, Alexander E.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[39] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Rieke, D. T.
Lin, Iyeong J.
Tan, D. S.
Kummar, S.
Patel, J. D.
Cermignani, L.
Dai, M. -S.
Lassen, U. N.
Leyvraz, S.
Liu, Y.
Moreno, V.
Rosen, L.
Saada-Bouzid, E.
Solomon, B.
Xu, R. -H.
Yachnin, J.
Norenberg, R.
Burcoveanu, D. -I.
Mussi, C. E.
Shen, L.
Drilon, A.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 9 - 10
[40] Long-term efficacy and safety of larotrectinib in patients with TRK fusion-positive lung cancer.
Lin, Jessica Jiyeong
Kummar, Shivaani
Tan, Daniel Shao-Weng
Lassen, Ulrik Niels
Leyvraz, Serge
Liu, Yongmei
Moreno, Victor
Patel, Jyoti D.
Rosen, Lee S.
Solomon, Benjamin Maurice
Norenberg, Ricarda
Dima, Laura
Brega, Nicoletta
Shen, Lin
Drilon, Alexander E.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →